Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: What impact on outcomes and carbapenem exposure?

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 4, 2016, Pages 1088-1097

  Barbier, François ^a   Pommier, Cécile ^b   Essaied, Wafa ^b   Garrouste Orgeas, Maïté ^c   Schwebel, Carole ^d   Ruckly, Stéphane ^b,e   Dumenil, Anne Sylvie ^f   Lemiale, Virginie ^g   Mourvillier, Bruno ^h   Clec'h, Christophe ⁱ   Darmon, Michaël ^j   Laurent, Virginie ^k   Marcotte, Guillaume ^l   Lucet, Jean Christophe ^b,h   Souweine, Bertrand ^m   Zahar, Jean Ralph ⁿ   Timsit, Jean Françoison ^b,h   Azoulay, Elie ^g   Cohen, Yves ⁱ   Soufir, Lilia ^c   Adrie, Christophe ^o   Alberti, Corinne ^p   Français, Adrien ^q   Vesin, Aurélien ^r   Lecorre, Frederik ^s   Nakache, Didier ^t   Vannieuwenhuyze, Aurélien ^u   Allaouchiche, Bernard ^v   Argaut, Laurent ^w   Ara Somohano, Claire ^d   Bedos, Jean Pierre ^x   Bohé, Julien ^y   Bouadma, Lila ^h   Boyer, Alexandre ^z   Cheval, Christine ^aa   Colin, Jean Pierre ^ab   Descorps Declere, Adrien ^ac   Fosse, Jean Philippe ^o   Gainier, Marc ^ad   Haouache, Akim ^ae   Jamali, Samir ^ab   Khallel, Hatem ^af   Lautrette, Alexandre ^m   Le Miere, Eric ^ag   Lugosi, Maxime ^d   Montesino, Laurent ^h   Misset, Benoît ^c   Moreau, Delphine ^g   Papazian, Laurent ^ah   Planquette, Benjamin ^x   Pigné, Etienne ^ag   Troché, Gilles ^ai   Thuong, Marie ^aj   Thierry, Guillaume ^g   Toledano, Dany ^ak   Vantalon, Eric ^c   Fournier, Julien ^u   Tournegros, Caroline ^u   Bagur, Stéphanie ^u   Vindrieux, Vanessa ^u   Ferrand, Loic ^u   Kaddour, Nadira ^u   Berthe, Boris ^u   Bekkhouche, Samir ^u   Anselme, Sylvain ^u   Mellouk, Kaouttar ^u   Conrozier, Sylvie ^u   Theodose, Igor ^u   Deiler, Veronique ^u   Letrou, Sophie ^u   more..

^a CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c SAINT JOSEPH HOSPITAL   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e Department of Biostatistics   (France)

^f HÔPITAL ANTOINE BÉCLÈRE   (France)

^g SAINT LOUIS HOSPITAL   (France)

^h BICHAT HOSPITAL   (France)

ⁱ AVICENNE HOSPITAL   (France)

^j UNIVERSITÉ JEAN MONNET   (France)

^k CENTRE HOSPITALIER DE VERSAILLES   (France)

^l EDOUARD HERRIOT HOSPITAL   (France)

^m SERVICE DE RHUMATOLOGIE   (France)

ⁿ ANGERS UNIVERSITY HOSPITAL   (France)

^o Institut Cochin   (France)

^p HÔPITAL ROBERT DEBRÉ   (France)

^q Integrated Research Center U823   (France)

^r OUTCOMEREA organization and Integrated Research Center U823   (France)

^s SUPELEC   (France)

^t University of Paris Cité   (France)

^u OUTCOMEREA organization and Integrated Research Center U823 ^*

^v University Hospital Pierre Benite   (France)

^w HOSPICES CIVILS DE LYON   (France)

^x CENTRE HOSPITALIER DE VERSAILLES   (France)

^y CENTRE HOSPITALIER LYON SUD   (France)

^z HÔPITAL PELLEGRIN   (France)

^aa Hyeres Hospital   (France)

^ab Dourdan Hospital   (France)

^ac Surgical ICU Antoine Béclre University Hospital   (France)

^ad TIMONE HOSPITAL   (France)

^ae HENRI MONDOR HOSPITAL   (France)

^af Parasitology Mycology Laboratory   (France)

^ag HÔPITAL LOUIS MOURIER   (France)

^ah HÔPITAL NORD   (France)

^ai Service de Pneumologie   (France)

^aj DELAFONTAINE HOSPITAL   (France)

^ak Gonesse Hospital   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BLOODSTREAM INFECTION; CATHETER INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG EXPOSURE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY (TOPIC); NONHUMAN; RISK ASSESSMENT; SURGICAL INFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION; BIOSYNTHESIS; CAUSE OF DEATH; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GENETICS; HEALTH SURVEY; HOSPITAL MORTALITY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL;

AGED; BETA-LACTAMASES; CARBAPENEMS; CAUSE OF DEATH; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS;

EID: 84964330065     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv423     Document Type: Article

References (40)

1. Center for Diseases Control and Prevention Threat Report 2013. www.cdc.gov.
2. Bassetti M, De Waele JJ, Eggimann P et al. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 2015; 41: 776-95.
3. Ruppé E, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care 2015; 5: 21.
4. Sader HS, Farrell DJ, Flamm RK et al. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011). Diagn Microbiol Infect Dis 2014; 78: 443-8.
5. Meyer E, Schwab F, Schroeren-Boersch B et al. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 2010; 14: R113.
6. European Center for Disease Control and Prevention European Antimicrobial Resistance Surveillance (EARS-Net) 2013. www.http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance.
7. Rosenthal VD, Bijie H, Maki DG et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control 2012; 40: 396-407.
8. Chung DR, Song JH, Kim SH et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 2011; 184: 1409-17.
9. Razazi K, Derde LP, Verachten M et al. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit. Intensive Care Med 2012; 38: 1769-78.
10. Torres A, Cilloniz C, Ferrer M et al. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis. Eur Respir J 2015; 45: 1353-63.
11. Cohen J, Vincent JL, Adhikari NK et al. Sepsis: a roadmap for future research. Lancet Infect Dis 2015; 15: 581-614.
12. Hyle EP, Lipworth AD, Zaoutis TE et al. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: variability by site of infection. Arch Intern Med 2005; 165: 1375-80.
13. Anderson DJ, Engemann JJ, Harrell LJ et al. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 2006; 50: 1715-20.
14. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 913-20.
15. Rottier WC, Ammerlaan HS, Bonten MJ. Effects of confounders and intermediates on the association of bacteraemia caused by extendedspectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother 2012; 67: 1311-20.
16. de Kraker ME, Wolkewitz M, Davey PG et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 2011; 66: 398-407.
17. Shorr AF. Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med 2009; 37: 1463-9.
18. Tumbarello M, Spanu T, Sanguinetti M et al. Bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 2006; 50: 498-504.
19. Marra AR, Wey SB, Castelo A et al. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum β-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis 2006; 6: 24.
20. Bhavnani SM, Ambrose PG, Craig WA et al. Outcomes evaluation of patients with ESBL-and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 2006; 54: 231-6.
21. Pena C, Pujol M, Ardanuy C et al. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extendedspectrum β-lactamase. J Hosp Infect 2001; 47: 53-9.
22. Lambert ML, Suetens C, Savey A et al. Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study. Lancet Infect Dis 2011; 11: 30-8.
23. Thiebaut AC, Arlet G, Andremont A et al. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units. J Antimicrob Chemother 2012; 67: 1525-36.
24. Harris AD, McGregor JC, Johnson JA et al. Risk factors for colonization with extended-spectrum β-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007; 13: 1144-9.
25. Zahar JR, Garrouste-Orgeas M, Vesin A et al. Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events. Intensive Care Med 2013; 39: 2153-60.
26. Canton R, Akova M, Carmeli Y et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012; 18: 413-31.
27. Venot M, Weis L, Clec'h C et al. Acute kidney injury in severe sepsis and septic shock in patients with and without diabetes mellitus: a multicenter study. PLoS One 2015; 10: e0127411.
28. Center for Diseases Control and Prevention Healthcare-associated infections. www.cdc.gov/nhsn.
29. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol 2009; 170: 244-56.
30. Dumartin C, L'Heriteau F, Pefau et al. Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. J Antimicrob Chemother 2010; 65: 2028-36.
31. Dautzenberg MJ, Wekesa AN, Gniadkowski M et al. The association between colonization with carbapenemase-producing Enterobacteriaceae and overall ICU mortality: an observational cohort study. Crit Care Med 2015; 43: 1170-7.
32. Lee SY, Kotapati S, Kuti JL et al. Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 2006; 27: 1226-32.
33. Kaier K, Meyer E, Dettenkofer M et al. Epidemiology meets econometrics: using time-series analysis to observe the impact of bed occupancy rates on the spread of multidrug-resistant bacteria. J Hosp Infect 2010; 76: 108-13.
34. Bretonnière C, Leone M, Milesi C et al. Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric). Intensive Care Med 2015; 41: 1181-96.
35. Zilberberg MD, Chen J, Mody SH et al. Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med 2010; 10: 45.
36. Corbella X, Montero A, Pujol M et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000; 38: 4086-95.
37. Armand-Lefevre L, Angebault C, Barbier F et al. Emergence of imipenem-resistant Gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 2013; 57: 1488-95.
38. Papadimitriou-Olivgeris M, Marangos M, Fligou F et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 2012; 67: 2976-81.
39. Harris PN, Tambyah PA, Paterson DL. β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of fewantibiotic options? Lancet Infect Dis 2015; 15: 475-85.
40. Ruppé E, Andremont A. Causes, consequences, and perspectives in the variations of intestinal density of colonization of multidrug-resistant enterobacteria. Front Microbiol 2013; 4: 129.